Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer.

Grøndahl-Hansen, J; Peters, H A; van Putten, W L; Look, M P; Pappot, H; Rønne, E; Dano, K; Klijn, J G; Brünner, N; Foekens, J A

Grøndahl-Hansen, J; Peters, H A; van Putten, W L; Look, M P; Pappot, H; Rønne, E; Dano, K; Klijn, J G; Brünner, N; Foekens, J A.

Affiliation

Grøndahl-Hansen J; Finsen Laboratory, Rigshospitalet, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.

Clin Cancer Res ; 1(10): 1079-87, 1995 Oct.

Article in En | MEDLINE | ID: mdl-9815897

Subject(s)

Breast Neoplasms/chemistry; Neoplasm Proteins/analysis; Receptors, Cell Surface/analysis; Adult; Aged; Aged, 80 and over; Analysis of Variance; Cytosol/chemistry; Disease-Free Survival; Female; Humans; Middle Aged; Prognosis; Receptors, Urokinase Plasminogen Activator

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 3_ND / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Cell Surface / Neoplasm Proteins Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Year: 1995 Document type: Article

Search on Google

XML

PubMed Links